GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by GSK Plc on October 3, 2022, for the month of October 2022. The filing serves as a notification to the market in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R regarding the Company's total voting rights and capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a capital structure notification rather than a financial results report.
Material Changes
The filing details the Company's issued share capital as of September 30, 2022:
- Total issued shares: 4,311,302,410 Ordinary Shares of 31 1/4 pence each.
- Treasury shares held: 243,924,760 Ordinary Shares.
- Total voting rights: 4,067,377,650.
This figure is provided to assist shareholders in calculating notification thresholds under the Financial Conduct Authority's rules.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total voting rights count of 4,067,377,650 for compliance calculations.
- Confirm the number of treasury shares held is 243,924,760 as of September 30, 2022.
- Note that this filing contains no operational or financial performance data.